Halozyme Therapeutics, Inc. (HALO)
67.30
+0.18
(+0.27%)
USD |
NASDAQ |
May 18, 12:11
Halozyme Therapeutics Profit Margin (Quarterly) : 39.83% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 34.24% |
| Agenus, Inc. | -- |
| Inovio Pharmaceuticals, Inc. | -- |
| Curis, Inc. | -- |
| LadRx Corp. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 109.9% |
| Return on Assets | 14.71% |
| Return on Invested Capital | 16.71% |
| Gross Profit Margin (Quarterly) | 71.13% |
| Operating Margin (Quarterly) | 48.98% |
| Return on Net Operating Assets | 20.29% |